{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T23:05:38Z","timestamp":1772060738027,"version":"3.50.1"},"reference-count":13,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T00:00:00Z","timestamp":1535932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Uromedica, Inc."}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Neurourology and Urodynamics"],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>This paper presents 18\u2010month follow\u2010up results for patients enrolled in a pivotal study conducted to support an FDA premarket approval application (PMAA). The trial evaluated the safety and efficacy of the ProACT Adjustable Continence Therapy for the treatment of post\u2010prostatectomy stress urinary incontinence (SUI).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The clinical study involved 11 clinical sites and enrolled 160 subjects. A total of 124 subjects met study criteria and 123 underwent ProACT implantation from July 2005 through June 2007, of whom 98 completed 18\u2010month follow\u2010up. Endpoints included 24\u2010h pad weight, Incontinence Quality of Life Questionnaire (I\u2010QOL), UCLA Prostate Cancer Index\u2010Urinary Function (PCI\u2010UF), residual volume, and device or procedure\u2010related adverse events (AEs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mean surgical time was 32\u2009min. Statistically significant improvements during follow\u2010up were observed in 24\u2010h pad weight, for which the cohort mean pre\u2010implant urine loss was 399\u2009g, which was reduced at 18 months to 160\u2009g (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Reductions in pad weight were observed across all levels of pre\u2010implant SUI severity. Significant improvements were also seen in quality of life as measured by the I\u2010QOL (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) as well as measures of urinary function and pad count. One procedure\u2010related serious adverse event (SAE), retention, was reported among the 124 subjects; the SAE was resolved without clinical meaningful sequalae.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>These results demonstrate the safety and efficacy of this newly FDA\u2010approved therapy, showing significant improvements in objective and subjective measures of SUI in mild, moderate, and severely incontinent male patients. The duration of the implant procedure is short, and complications are mild and easily resolvable.<\/jats:p><\/jats:sec>","DOI":"10.1002\/nau.23802","type":"journal-article","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T06:39:27Z","timestamp":1536043167000},"page":"2854-2859","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Treatment with an adjustable long\u2010term implant for post\u2010prostatectomy stress incontinence: The ProACT\u2122 pivotal trial"],"prefix":"10.1002","volume":"37","author":[{"given":"Steven","family":"Nash","sequence":"first","affiliation":[{"name":"Kansas City Urology Care Leawood Kansas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif","family":"Aboseif","sequence":"additional","affiliation":[{"name":"Kaiser Permanente\u2010Los Angeles Los Angeles California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Gilling","sequence":"additional","affiliation":[{"name":"Urology Bay of Plenty Tauranga New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathew","family":"Gretzer","sequence":"additional","affiliation":[{"name":"University of Arizona Tucson Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey","family":"Samowitz","sequence":"additional","affiliation":[{"name":"The Pelvic Clinic Pembroke Pines Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Rose","sequence":"additional","affiliation":[{"name":"Indian River Urology Vero Beach Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Slutsky","sequence":"additional","affiliation":[{"name":"Urological Surgeons Kankakee Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Siegel","sequence":"additional","affiliation":[{"name":"Metro Urology Woodbury Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le Mai","family":"Tu","sequence":"additional","affiliation":[{"name":"CHUS\u2010Fleurimont Quebec Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,9,3]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(00)00539-2"},{"key":"e_1_2_7_3_1","first-page":"1679","article-title":"The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S","volume":"83","author":"Mittlin CJ","year":"1998","journal-title":"The American College of Surgeons Commission on Cancer and the American Cancer Society, Cancer"},{"key":"e_1_2_7_4_1","first-page":"351","volume-title":"Incontinence: 2nd International Consultation on Incontinence","author":"Homma Y","year":"2002"},{"key":"e_1_2_7_5_1","first-page":"2555","volume-title":"Campbell's Urology","author":"Eastham JA","year":"1998"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2013.01.020"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2009.11.031"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2005.05689.x"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2008.02161.x"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(98)00454-3"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.01.019"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.11.034"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2011.03.016"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2006.07.041"}],"container-title":["Neurourology and Urodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fnau.23802","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/nau.23802","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T08:54:18Z","timestamp":1694681658000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/nau.23802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,3]]},"references-count":13,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["10.1002\/nau.23802"],"URL":"https:\/\/doi.org\/10.1002\/nau.23802","archive":["Portico"],"relation":{},"ISSN":["0733-2467","1520-6777"],"issn-type":[{"value":"0733-2467","type":"print"},{"value":"1520-6777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,3]]},"assertion":[{"value":"2018-06-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}